{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/gynaecological-cancers-recognition-referral/goals-outcome-measures/nice-quality-standards/","result":{"pageContext":{"chapter":{"id":"f4beaa7f-d7cd-576b-8692-c4516abd0c56","slug":"nice-quality-standards","fullItemName":"NICE quality standards","depth":2,"htmlHeader":"<!-- begin field cae52ded-69ac-489d-bf5d-7109836fdb40 --><h2>NICE quality standards</h2><!-- end field cae52ded-69ac-489d-bf5d-7109836fdb40 -->","summary":null,"htmlStringContent":"<!-- begin item 1598aedb-0e1e-438c-b435-9d5236a926be --><!-- begin field 64099bad-4884-4d50-8d5c-36ab396070d4 --><ul><li>GPs have direct access to diagnostic endoscopy, ultrasound, MRI, X-ray and CT for people with suspected cancer.</li><li>People presenting in primary care with symptoms that suggest oesophageal or stomach cancer have an urgent direct access upper gastrointestinal endoscopy.</li><li>Adults presenting in primary care with symptoms that suggest colorectal cancer, who do not meet the referral pathway criteria, have a test for blood in their faeces.</li><li>People with suspected cancer who are referred to a cancer service are given written information encouraging them to attend.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/gynaecological-cancers-recognition-referral/references/\">NICE, 2016</a>]</p><!-- end field 64099bad-4884-4d50-8d5c-36ab396070d4 --><!-- end item 1598aedb-0e1e-438c-b435-9d5236a926be -->","topic":{"id":"ee6103b8-1f49-5865-acd7-5a9d20d194e6","topicId":"e261ffa1-7f7e-430a-9e12-c985aaca7f4d","topicName":"Gynaecological cancers - recognition and referral","slug":"gynaecological-cancers-recognition-referral","lastRevised":"Last revised in February 2021","chapters":[{"id":"65e105c6-5f7b-59ad-9801-824c409f981c","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"e401d47d-3905-5eda-b3cd-1b4eef408bdf","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"e31afef3-1c88-506d-ad84-0a6b30b9dba1","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"278052bd-be26-5c26-84bc-2113aee7dc30","slug":"changes","fullItemName":"Changes"},{"id":"efc1c0f8-bdb1-5114-97b1-648a6a52a459","slug":"update","fullItemName":"Update"}]},{"id":"e8e62e95-f70c-5b2b-9b10-0c9c5f2e9c95","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"f85ffb79-0957-5932-821c-906cec331a84","slug":"goals","fullItemName":"Goals"},{"id":"7d1d0b80-0602-5d4c-98eb-6a49f27689c0","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"9244c05b-86d8-5f85-b189-5479cde68eeb","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"b605e7ea-7a24-5403-96d0-e0fac5a89219","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"703f3f20-548e-5808-a218-c091ab3b216f","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"f4beaa7f-d7cd-576b-8692-c4516abd0c56","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"e14ce3a1-8460-551b-a361-43faa360c514","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"47f1f404-6941-5185-bcab-0175066bad01","slug":"presentation","fullItemName":"Presentation"},{"id":"a9c43384-a7d0-51f4-8d73-6b71541884df","slug":"prevalence","fullItemName":"Prevalence"},{"id":"044108ce-710b-5ec8-a3ae-429b107039bf","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"9da77476-bb29-59ac-a917-0d3da982f80f","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"8a44798e-bc7c-5377-9f3c-b743ee5a7af7","slug":"symptoms-suggestive-of-gynaecological-cancers","fullItemName":"Symptoms suggestive of gynaecological cancers"}]},{"id":"b5a02174-cd66-5e92-9819-0302058cf230","fullItemName":"Management","slug":"management","subChapters":[{"id":"415eae91-f38a-5ccc-95f0-68d5ca386095","slug":"referral-for-suspected-gynaecological-cancer","fullItemName":"Scenario: Referral for suspected gynaecological cancer"}]},{"id":"8f87e182-3ee3-55c3-b6ff-ee2773b11083","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"7030c633-3342-56a4-872a-5d01b1950d05","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"3e4a0622-59ba-59f1-a249-25f37835db8f","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"598e9e20-db1b-5bd6-bad9-da74dd559795","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d01e7124-01f5-52fc-a22b-2f245daf8632","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"e5593853-81b8-58eb-a621-1e437e26ef58","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"06edaae5-710d-5a2f-8d9f-e20e29be3d6e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"4aae08c9-f011-5561-8ca0-183457de55ec","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"e8e62e95-f70c-5b2b-9b10-0c9c5f2e9c95","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}